Latanoprost

C7H7Br 100-39-0) see Fosinopril Latanoprost Monobenzone Orlistat Pirbuterol Saquinavir benzyl bromoacetate... 

C12H10 92-52-4) see Bifonazole Fenbufen 4-biphenylacetonitrile (C14H11N J760i-77-7) see Felbinac [3aR-(3aa,4a,5p,6aa)]-[l,l -biphenyl]-4-carboxylic acid 4-formylhexahydro-2-oxo-2fl-cyclopenta[6]furan-5-yl ester (C2iH,80j 38754-71-1) see Latanoprost [3alt-[3aa,4a(l ,35 ),5p,6aa]]-[4,4 -biphenyl]-4-carb-oxylic acid hexahydro-4-(3-hydroxy-5-phenyl-l-pentenyl)-2-oxo-21/-cyclopenta[6]furan-5-yl ester (C3 H ,05 41639-73-0) see Latanoprost... 

C31H28O5 41639-72-9) see Latanoprost 4,4 -bis(acetamido)diphenyl sulfide (C ( H (iN202S 7355-56-8) see Dapsone 4,4 -bis(acetamido)diphenyl sulfone (C,9H fiN204S 77-46-3) see Dapsone... 

C21H20O5 31752-99-5) see Dinoprost Latanoprost Unoprostone isopropyl cortisol 21-acetate... 

C3H4O3 127-17-3) see Perindopril (2-oxopropyl)phosphonic acid dimethyl ester (C5H),04P 4202-14-6) see Latanoprost 11 -oxo-3-(l-pyrrolidinyl)prcgna-3,5,17(20)-trien-21-oic acid methyl ester... 

Prostaglandin Analogs Latanoprost Prostaglandin Xalatan Solution 0.005 1 drop every night Increases aqueous... 

The ocular hypotensive lipids in typical ophthalmology practice are considered first-line alternatives to topical P-blockers because of their superior efficacy and safety profiles. Many clinicians may choose to use the ocular hypotensive lipids as first-line agents, especially in patients that have an initial requirement to lower IOP by more than 25%, or in patients that have relative or absolute contraindications to topical P-blockers. However, latanoprost is currently the only ocular hypotensive lipid drug that has a Food and Drug Administration (FDA) indication for first-line therapy. Bimatoprost and travoprost are indicated by the FDA for patients who are intolerant of other IOP-lowering therapy or insufficiently responsive to another IOP-lowering medication.10,38... 

Prostaglandin analogs Latanoprost Prostaglandin F2a analog Xalatan Solution... 

Drug therapy of an acute attack typically consists of an osmotic agent and secretory inhibitor (e.g., /1-blocker, a2 agonist, latanoprost, or CAI), with or without pilocarpine. 

Xalatan drops is a proprietary preparation of latanoprost (prostaglandin analogue), indicated in glaucoma. 

Xalatan (latanoprost) is a prostaglandin analogue, which increases the uvoscleral outflow, thereby decreasing the intraocular pressure. The drops, which are applied once daily, preferably in the evening, may cause eye discoloration especially in patients with mixed colour irides. 

Q84 In patients with a history of asthma, latanoprost is a preferred first-line treatment in open-angle glaucoma. Latanaprost is available as eye drops and once-daily application in the evening is recommended. 

---